We conducted studies to determine at what time point an add-on prothro
mbin time (PT) or activated partial thromboplastin time (APTT) test ca
n be honored on specimens that have been received in the laboratory ho
urs earlier without yielding results with clinically significant diffe
rences from those if the test had been performed on the original unsto
red plasma. PT and APTT tests were performed on blood samples from 20
healthy subjects, 30 patients receiving warfarin, and 30 patients rece
iving heparin anticoagulation therapy The tests were performed on plas
ma prepared initially after the samples were obtained. The same tests
were assayed on plasma that had been left on spun-down blood cells at
room temperature for 2, 4, and 8 hours. We found that the PT of the ma
jority of plasma samples from healthy subjects and from patients recei
ving oral anticoagulant therapy tended to become shorter on storage. H
owever, the difference in PT values was small and had no clinical sign
ificance. In most cases, the APTT values for the stored plasma from he
althy subjects tended to increase with time. Except in one specimen in
which the 8-hour add-on APTT was 1.2 seconds longer than the APTT res
ult for the original sample, all others had APTT results less than 1.2
seconds longer than the original values. In patients receiving hepari
n, the differences in APTT values between the initial and add-on tests
were larger than those observed for healthy subjects. However, those
differences are not beyond what we would accept for duplicate checks f
or heparinized samples with high APTT values. Unlike samples from heal
thy subjects, there was no obvious trend of time-related prolongation
of the APTT in heparinized plasma. These results led us to believe tha
t within an 8-hour period and with plasma on spun-down cells at room t
emperature, add-on tests for PT and APTT could be performed with resul
ts similar to what would be obtained from testing unstored samples.